Eugene Williams - Net Worth and Insider Trading

Eugene Williams Net Worth

The estimated net worth of Eugene Williams is at least $241,494 dollars as of 2024-06-23. Eugene Williams is the Director of ProMIS Neurosciences Inc and owns about 159,930 shares of ProMIS Neurosciences Inc (PMN) stock worth over $241,494. Details can be seen in Eugene Williams's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eugene Williams has not made any transactions after 2022-12-16 and currently still holds the listed stock(s).

Transaction Summary of Eugene Williams

To

Eugene Williams Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eugene Williams owns 1 companies in total, including ProMIS Neurosciences Inc (PMN) .

Click here to see the complete history of Eugene Williams’s form 4 insider trades.

Insider Ownership Summary of Eugene Williams

Ticker Comapny Transaction Date Type of Owner
PMN ProMIS Neurosciences Inc 2022-12-16 director & Chairman and CEO

Eugene Williams Latest Holdings Summary

Eugene Williams currently owns a total of 1 stock. Eugene Williams owns 159,930 shares of ProMIS Neurosciences Inc (PMN) as of December 16, 2022, with a value of $241,494.

Latest Holdings of Eugene Williams

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PMN ProMIS Neurosciences Inc 2022-12-16 159,930 1.51 241,494

Holding Weightings of Eugene Williams


Eugene Williams Form 4 Trading Tracker

According to the SEC Form 4 filings, Eugene Williams has made a total of 5 transactions in ProMIS Neurosciences Inc (PMN) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in ProMIS Neurosciences Inc is the acquisition of 2,000 shares on December 16, 2022, which cost Eugene Williams around $9,300.

Insider Trading History of Eugene Williams

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eugene Williams Trading Performance

GuruFocus tracks the stock performance after each of Eugene Williams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eugene Williams is -14.34%. GuruFocus also compares Eugene Williams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eugene Williams within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eugene Williams's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eugene Williams

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.3 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -15.51 LIMIT LIMIT LIMIT LIMIT LIMIT

Eugene Williams Ownership Network

Ownership Network List of Eugene Williams

No Data

Ownership Network Relation of Eugene Williams

Insider Network Chart

Eugene Williams Owned Company Details

What does ProMIS Neurosciences Inc do?

Who are the key executives at ProMIS Neurosciences Inc?

Eugene Williams is the director & Chairman and CEO of ProMIS Neurosciences Inc. Other key executives at ProMIS Neurosciences Inc include Chief Medical Officer Larry Douglas Altstiel , Chief Financial Officer Daniel E. Geffken , and 10 percent owner Jeremy M. Sclar .

ProMIS Neurosciences Inc (PMN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ProMIS Neurosciences Inc (PMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ProMIS Neurosciences Inc (PMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ProMIS Neurosciences Inc (PMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ProMIS Neurosciences Inc Insider Transactions

No Available Data

Eugene Williams Mailing Address

Above is the net worth, insider trading, and ownership report for Eugene Williams. You might contact Eugene Williams via mailing address: C/o Promis Neurosciences Inc., Suite 200, 1920 Yonge Street, Toronto A6 M4s 3e2.

Discussions on Eugene Williams

No discussions yet.